Header cover image

Investing Ideas
/
Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Results

17

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

17 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	BANB Bachem Holding	CHF 68.50	-10.4%	-3.5%	CHF 5.1b	CHF 85.00	PE45.2x	E17.9%	1.2%
	KURN Kuros Biosciences	CHF 20.05	-30.3%	455.4%	CHF 753.3m	n/a	PS14.3x	n/a	n/a
	COPN Cosmo Pharmaceuticals	CHF 62.70	-2.8%	56.9%	CHF 1.0b	CHF 97.30	PE15.5x	E17.2%	3.0%
	MOLN Molecular Partners	CHF 5.15	-4.6%	33.4%	CHF 189.8m	CHF 9.75	PS31.6x	E-1.2%	n/a
	SKAN SKAN Group	CHF 71.00	-6.8%	-4.4%	CHF 1.6b	CHF 90.00	PE49.5x	E18.7%	0.5%
	TECN Tecan Group	CHF 208.80	-4.6%	-31.2%	CHF 2.7b	CHF 286.14	PE26.4x	E14.2%	1.4%
	DESN Dottikon ES Holding	CHF 232.50	-6.1%	11.0%	CHF 3.2b	n/a	PE39.8x	S14.5%	0%
	LONN Lonza Group	CHF 507.80	-8.2%	42.2%	CHF 36.7b	CHF 631.85	PE64x	E23.9%	0.8%
	ADXN Addex Therapeutics	CHF 0.062	-20.8%	38.6%	CHF 6.1m	CHF 0.16	PS7x	E33.3%	n/a
	BSLN Basilea Pharmaceutica	CHF 39.80	-4.8%	10.6%	CHF 482.4m	CHF 77.25	PS3.2x	E20.1%	0%
	SANN Santhera Pharmaceuticals Holding	CHF 8.03	-3.8%	-18.6%	CHF 97.2m	CHF 32.00	PE1.5x	E35.4%	n/a
	OBSN ObsEva	CHF 0.0012	0%	-98.2%	CHF 140.6k	n/a	PE0.02x	n/a	n/a
	RLF Relief Therapeutics Holding	CHF 5.00	-24.5%	167.4%	CHF 62.7m	n/a	PS7.3x	n/a	n/a
	PPGN PolyPeptide Group	CHF 27.15	-11.6%	37.5%	CHF 895.5m	CHF 36.25	PS3x	E64.2%	0%
	NOVN Novartis	CHF 91.22	-2.0%	8.2%	CHF 182.4b	n/a	PE17.5x	E7.0%	3.5%
	GALD Galderma Group	CHF 85.18	0.5%	n/a	CHF 20.2b	CHF 89.49	PS5.3x	E44.4%	n/a
	SFZN Siegfried Holding	CHF 1,096.00	-3.0%	39.3%	CHF 4.7b	CHF 1,187.67	PE36.5x	E13.6%	0.3%

Page 1 of 1